Home
About
Overview
Sharing Data
ORCID
Help
History (7)
IMAGING OXYGEN--LOW FREQUENCY ELECTRON SPIN RESONANCE
Reimagining Neonatal Follow-Up: An Equitable Model of Care Emphasizing Family and Child Function.
Treat or Wait? Natural Perioperative Course of Overactive Bladder Symptoms at the Time of Midurethral Sling Placement.
The 2021 Pediatric Hospital Medicine Workforce: Results of a National Survey of Program Leaders.
Five-Year Efficacy and Safety of Ustekinumab Treatment in Crohn's Disease: The IM-UNITI Trial.
See All 7 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Five-Year Efficacy and Safety of Ustekinumab Treatment in Crohn's Disease: The IM-UNITI Trial.
Five-Year Efficacy and Safety of Ustekinumab Treatment in Crohn's Disease: The IM-UNITI Trial. Clin Gastroenterol Hepatol. 2022 03; 20(3):578-590.e4.
View in:
PubMed
subject areas
Crohn Disease
Humans
Induction Chemotherapy
Maintenance Chemotherapy
Remission Induction
Treatment Outcome
Ustekinumab
authors with profiles
Stephen B. Hanauer